Literature DB >> 16039993

Role of PYK2 in the development of obesity and insulin resistance.

Ying Yu1, Stuart A Ross, Amy E Halseth, Paul W Hollenbach, Ronald J Hill, Eric A Gulve, Brian R Bond.   

Abstract

Non-receptor proline-rich tyrosine kinase-2 (PYK2), which is activated by phosphorylation of one or more of its tyrosine residues, has been implicated in the regulation of GLUT4 glucose transporter translocation and glucose transport. Some data favor a positive role of PYK2 in stimulating glucose transport, whereas other studies suggest that PYK2 may participate in the induction of insulin resistance. To ascertain the importance of PYK2 in the setting of obesity and insulin resistance, we (1) evaluated the regulation of PYK2 in mice fed a high-fat diet and (2) characterized body and glucose homeostasis in wild type (WT) and PYK2(-/-) mice on different diets. We found that both PYK2 expression and phosphorylation were significantly increased in liver and adipose tissues harvested from high-fat diet fed mice. Wild type and PYK2(-/-) mice were fed a high-fat diet for 8 weeks to induce insulin resistance/obesity. Surprisingly, in response to this diet PYK2(-/-) mice gained significantly more weight than WT mice (18.7+/-1.2g vs. 9.5+/-0.6g). Fasting serum leptin and insulin and blood glucose levels were significantly increased in high-fat diet fed mice irrespective of the presence of PYK2 protein. There was a close correlation between serum leptin and body weight. Intraperitoneal glucose tolerance tests revealed that as expected, the high-fat diet resulted in increased blood glucose levels following glucose administration in wild type mice compared to those fed normal chow. An even greater increase in blood glucose levels was observed in PYK2(-/-) mice compared to wild type mice. These results demonstrate that a lack of PYK2 exacerbates weight gain and development of glucose intolerance/insulin resistance induced by a high-fat diet, suggesting that PYK2 may play a role in slowing the development of obesity, insulin resistance, and/or frank diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039993     DOI: 10.1016/j.bbrc.2005.06.198

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  The nonreceptor protein tyrosine kinase Pyk2 promotes the turnover of monocytes at steady state.

Authors:  Ryan A Llewellyn; Keena S Thomas; Michael F Gutknecht; Amy H Bouton
Journal:  J Leukoc Biol       Date:  2017-07-28       Impact factor: 4.962

2.  A role for focal adhesion kinase in facilitating the contractile responses of murine gastric fundus smooth muscles.

Authors:  Yeming Xie; Koon Hee Han; Nathan Grainger; Wen Li; Robert D Corrigan; Brian A Perrino
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

3.  Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis.

Authors:  Leonard Buckbinder; David T Crawford; Hong Qi; Hua Zhu Ke; Lisa M Olson; Kelly R Long; Peter C Bonnette; Amy P Baumann; John E Hambor; William A Grasser; Lydia C Pan; Thomas A Owen; Michael J Luzzio; Catherine A Hulford; David F Gebhard; Vishwas M Paralkar; Hollis A Simmons; John C Kath; W Gregory Roberts; Steven L Smock; Angel Guzman-Perez; Thomas A Brown; Mei Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-30       Impact factor: 11.205

4.  Targeting the hepatocyte growth factor-cMET axis in cancer therapy.

Authors:  George R Blumenschein; Gordon B Mills; Ana M Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

5.  Regulation of osteoclast structure and function by FAK family kinases.

Authors:  Brianne J Ray; Keena Thomas; Cynthia S Huang; Michael F Gutknecht; Edward A Botchwey; Amy H Bouton
Journal:  J Leukoc Biol       Date:  2012-08-31       Impact factor: 4.962

6.  Non-redundant functions of FAK and Pyk2 in intestinal epithelial repair.

Authors:  Keena S Thomas; Katherine A Owen; Kathryn Conger; Ryan A Llewellyn; Amy H Bouton; James E Casanova
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

7.  A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.

Authors:  James A Timmons; Andrew Anighoro; Robert J Brogan; Jack Stahl; Claes Wahlestedt; David Gordon Farquhar; Jake Taylor-King; Claude-Henry Volmar; William E Kraus; Stuart M Phillips
Journal:  Elife       Date:  2022-01-17       Impact factor: 8.713

8.  Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design.

Authors:  Seungil Han; Anil Mistry; Jeanne S Chang; David Cunningham; Matt Griffor; Peter C Bonnette; Hong Wang; Boris A Chrunyk; Gary E Aspnes; Daniel P Walker; Arthur D Brosius; Leonard Buckbinder
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

9.  Focal adhesion kinases in adhesion structures and disease.

Authors:  Pierre P Eleniste; Angela Bruzzaniti
Journal:  J Signal Transduct       Date:  2012-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.